Revvity, Inc. RVTY recently introduced Signals Xynthetica, a next-generation AI-augmented design platform aimed at transforming molecular and materials discovery across scientific industries.
WALTHAM, Mass.--(BUSINESS WIRE)-- Today, Revvity, Inc. (NYSE: RVTY) announced that its software and informatics division, Revvity Signals, is unveiling the Signals ClinicalTM solution, a software-as-a ...
Scalable collaboration for biotech and pharma teams: Enables high-throughput construct design (up to 1,000 constructs) with real-time data sharing Integrated, AI-ready biologics ecosystem: Connects ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
WALTHAM, Mass.--(BUSINESS WIRE)--Today, Revvity, Inc. (NYSE: RVTY) announced that its software and informatics division, Revvity Signals, will launch Signals Synergy TM, a software solution designed ...
WALTHAM, Mass.--(BUSINESS WIRE)--Today, Revvity, Inc. (NYSE: RVTY) announced that its software and informatics division, Revvity Signals Software, is introducing the new Signals ChemDraw ® offering, ...
Revvity's 2025 Guidance Signals Cautious Optimism Amid Slower-Than-Expected Pharma Spending Recovery
After significant business transformation activities in recent years, Revvity (formerly PerkinElmer) has been in a constant state of evolution since 2016 when the company made the transition into two ...
PerkinElmer’s life science and diagnostics spinoff rebranded as Revvity earlier this week. The company, which serves customers across the pharmaceutical, biotech, diagnostic labs sectors, said in a ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results